Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NPC1 | O15118 | 1/20 | 0.32 |
| ▸ | MAPT | P10636 | 1/20 | 0.32 |
| ▸ | RAB9A | P51151 | 1/20 | 0.32 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.31 |
| ▸ | ADAMTS5 | Q9UNA0 | 1/20 | 0.30 |
| ▸ | EGLN1 | Q9GZT9 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20284478 | 0.88 | ALDH1A1 (0.35) | MAPTADAMTS5EGLN1 | |
| SCHEMBL3197044 | 0.87 | PDK2 (0.33) | MAPTKDM4EADAMTS5EGLN1 | |
| SCHEMBL3205939 | 0.81 | PDK2 (0.34) | NPC1RAB9AKDM4EEGLN1 | |
| SCHEMBL3186198 | 0.75 | ESR1 (0.36) | NPC1MAPTRAB9AKDM4EADAMTS5 | |
| SCHEMBL3076018 | 0.74 | ALDH1A1 (0.38) | MAPTKDM4EADAMTS5EGLN1 | |
| SCHEMBL20202064 | 0.73 | ALDH1A1 (0.44) | ADAMTS5EGLN1 | |
| SCHEMBL10037388 | 0.72 | KDM4E (0.34) | MAPTKDM4E | |
| SCHEMBL2754782 | 0.70 | KDM4E (0.42) | MAPTKDM4EADAMTS5EGLN1 | |
| SCHEMBL3227987 | 0.70 | EGLN1 (0.33) | ADAMTS5EGLN1 | |
| SCHEMBL29156687 | 0.70 | ADAMTS5 (0.39) | MAPTADAMTS5EGLN1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20120001537-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | INDUSTRIAL TECHNOLOGY RESEARCH INSTITUTE (TW) | 2012-01-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120001537-A1 | ORGANIC COMPOUND AND ORGANIC ELECTROLUMINESCENCE DEVICE EMPLOYING THE SAME | OR10J3, ORC3, PIEZO1 | NPC1 2813/4885MAPT 1887/4885RAB9A 1473/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.